Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 7, 2009; 15(25): 3073-3085
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3073
Table 1 Human studies considering the anti-obesity effects of herbal medicines
AuthorsTargetHerbs (scientific name)StudyDose/durationGroupsMain outcomeOther relevant effects & complications
Ignjatovic et al[8] 2000Healthy volunteersSlimax: extract of several plants: Hordeum vulgare, Polygonatum multiflorum, Dimocarpus longan, Ligusticum sinense, Lilium brownie, and Zingiber officinaleRCT6 wkC: Placebo I: CompoundSig. decrease in body wt. & waist & hip Cir. & BMIModification of lipid metabolism with sig. effect on the accumulation & the release of lipid from adipose tissue
Boozer et al[9] 2001Over wt. (n = 35 )An herbal supplement: (Ma Huang & Guarana)RCT (double-blind)72 mg (ephedra) 240 mg (caffeine)/8 wkC: Placebo (n = 24) I: Compound (n = 24)Sig. decrease in body wt. & total body fat & sig. greater reduction in hip & waist Cir.Greater reduction in serum TG, potentially treatment-related dropouts (23%) in the active group and none in the placebo group. Dry mouth, insomnia & headache were reported
Hoeger et al[10] 1998HealthyA natural dietary compound of chromium picolinate, inulin, capsicum, L-phenylalanine, and other lipotropic nutrientsRCT (double-blind)4 wkC: wt. loss program (n = 67) I: wt. loss program + compound (n = 56)Sig. decrease in body fat percent, fat mass & FFM, but no sig. difference in body wt. BMI and energy intake
Ziauddin et al[11] 2004Hhyperlipidemic (n = 30)Terminalia arjuna RoxbBefore-after CTSig. improvement in obesity. Reduction in body wt. in some casesSig. decrease in serum total lipid levels. Sig. relief of palpitation, dyspnea, chest & joint pain. Reduction in BP in some cases
Abidov et al[12] 2006Obese non-diabetic women (n = 32)A compound of Aralia mandshurica (A) and Engelhardtia chrysolepis (E) extracts named ARALOXRCT450 mg (A) & 450 mg (E)/dC: Diet + placebo I: Diet + compoundDecrease in total body wt. & fat wt.Reduction in perilipin content in adipocytes and plasma TG. Stimulate activity of hormone sensitive lipase
Greenway et al[13] 2004Human (obese & over wt.) healthyHerbal supplement containing caffeine and ephedraRCT (double-blind)210 mg (e) & 72 mg (c)/12 wkC: Placebo I: CompoundSig. decrease in body wt. & the percentage of fatNo differences in lipid levels, or BP were shown. No serious adverse effect
Hioki et al[14] 2004Obese women with IGT (n = 80)Bofu-tsusho-san containing (Ephedrae Herba, Glycyrrhizae Radix, Forsythiae Fructus, Schizonepetae Spica &…)RCT (double-blind)Equivalent of (24 mg/ephedrine & 280 mg caffeine/24 wk)C: wt. loss program I: wt. loss program + compoundCompared to baseline the I group lost significantly more body wt. & abdominal visceral fat & the placebo group lost sig. body wt. & had no sig. change in abdominal visceral fatNo decrease in RMR. Sig. improvement in insulin resistance compared to week 0. Loose bowel movements resulted in three withdrawals
Oben et al[15] 2008Human (obese & over wt.)A combination of Cissus quadrangularis (CQ) & Irvingia gabonensis (IG)RCT (double-blind)300 mg (CQ) & 500 mg (IG) per day/10 wkC: Placebo I: CQ CQ + IGSig. decrease in body wt. & body fat percent & waist size in both I groups but the combination group (CQ + IG) resulted in larger reductionsSig. decrease in Chol & LDL of plasma and fasting blood glucose levels
Chrubasik et al[16] 2008Healthy (n = 80)A combination of Sambucus nigra (S) and Asparagus officinalis (A)Before-after CT(S): 1 mg anthocyanin, 370 mg flavonol, 150 mg hydroxycinnamate (A): 19 mg saponin per day-Sig. decrease in mean of the wt.Sig. improvement of BP, physical and emotional well-being and quality of life
Udani et al[17] 2007Healthy (n = 25)Proprietary fractionated white bean extractRCT (double-blind)2000 mg/14 wkC: Placebo + wt. loss program I: Extract + wt. loss programIn both groups, decrease in body wt. & waist size from baseline was sig. but no sig value between groupsThere were no adverse effect
Roongpisuthipong et al[18] 2007Obese womenCalcium hydroxycitrate in Garcinia atroviridisRCT2 moC: Diet I: Diet + extractSig. decrease in body wt. & greater reduction in BMI. Sig. decrease in the triceps skin fold thickness
Kuriyan et al[19] 2007Over wt. (n = 50)Caralluma fimbriataRCT1 g/60 dC: wt. loss program I: wt. loss program + extractSig. decrease in waist Cir. & hunger levels. Greater decrease in body wt., BMI, hip Cir., body fat & energy intake but not sig.
Hackman et al[20] 2007Obese & over wt. women (n = 41)Multinutrient supplement containing ephedra (e) and caffeine (c)RCT (double-blind)40 mg (e) and 100 mg (c)/9 moC: Control supplement I: Multinutrient supplementSig. decrease in body wt. decrease in appetiteSig. decline in serum chol, TG, glucose, fasting insulin & leptin levels & minor adverse effects like dry mouth, insomnia, ervousness and palpitation were reported
Garrison et al[21] 2006Over wt. womenProprietary extracts of Magnolia officinalis and phellodendron amurenseRCT750 mg/6 wkC: Placebo I: ExtractNo sig. wt. gain for the I group but sig. wt. gain in C. groupsThe I groups tended to have lower levels of cortisol in the evening
Coffey et al[22] 2004Human (over wt. & obese) (n = 102)Product containing ephedrine, caffeine & other ingredients.RCT (double-blind)12 wkC: Placebo I: CompoundAdditional wt. loss (1/5 kg) & greater reduction in BMI & waist Cir. No difference in body fat & fat mass percent was shownNo difference in pulse, diastolic & systolic BP & adverse events
Preuss et al[23] 2004Obese (n = 60)Hydroxycitric acid (HCA -SX) and a combination of HCA-SX and niacin-bound chromium (NBC) and Gymnema sylvestre extract (GSE)RCT (double-blind)HCA-SX: 4667 mg GSE: 400 mg NBC: 4 mg/8 wkC: Placebo I1 = HCA-SX I2 = GSE + NBC + HCA-SX All groups had wt. loss program5%-6% decrease in body wt. & BMI & sig. decrease in food intake in both I groupsSig. decrease in serum lipids & leptin & increase in HDL & excretion of urinary fat metabolites in both I groups. There were mild adverse effects but not significant between groups
Udani et al[24] 2004Obese (n = 24)A proprietary fractionated white bean (Phaseolus vulgaris)RCT (double-blind)3000 mg/8 wkC: Placebo I: ExtractDecrease of body wt. with 129% differenceReduction of TG three times greater than C. group. No adverse effect was shown
Bhatt et al[25] 1995Healthy (n = 58)Guggulu (Medohar)RCT1/5, 3 g/30 dC: wt. loss program I: wt. loss program + extractHigher mean wt. reduction in I group. In I group, all patients > 90 kg lost wt. but 3 in C group did not lose wt.
Oben et al[26] 2007Over wt. & obeseCissus quadrangularisRCT (double-blind)300, 1028 mgC: Placebo I: Two extract formulation: CQR-300, CORESig. decrease in body wt & body fatSig. decrease in serum lipids and glucose. Sig. increase in HDL-C plasma 5-HT and creatinine levels
Table 2 Animal studies on the anti-obesity effects of herbal medicines
AuthorsTargetHerbs (scientific name)Dose/durationGroupsMain outcomeOther relevant effects & complications
Wang et al[27] 2000Rat (obese)Haidonghua powder: Laminaria japonica Aresch & Benincasa hispida (Thunb.) Cogn. etc(2.5 g/kg)-Sig. decrease in Lee’s index & size of fat cellsDid not influence the function of thyroid gland & metabolism of water & salt
Jeon et al[28] 2003MouseRhus vemiciflua Stokes8 wkC: HFD I: HFD + extractSig. suppression of body wt. gain and lower wt. of subcutaneous adipose tissueLowered plasma TG
Alarcon-Aguilar et al[29] 2007MouseHibiscus sabdariffa120 mg/kg 60 dC: Healthy & obese (by MSG) + placebo I: Same groups + extractSig. decrease in body wt. gain in obese mice & increased liquid intake in both groupsNo sig. change in TG & Chol levels. Increase in ALT levels was shown but was not sig.
Urías-Silvas et al[30] 2008MouseFructans extracted from Agave tequilana (TEQ) and Dasylirion spp (DAS)10% supplementC: STD I: STD + Raftilose/DAS/TEQSig. decrease in body wt. gain & food intake. The (TEQ) group had the lowest valueLower serum glucose & Chol level but Sig. decrease in TG levels was shown in Raftilose group. Higher concentration of GLP-1 & it's precursor & proglucagon mRNA in I groups
Park et al[31] 2007RatPlatycodon grandiflorum150 mg/kg 7 wkC: NLD/HFD I: Same groups + extractSig. decrease in body wt & subcutaneous adipose tissue wt. & adipocytes size in I groupSig. decrease in plasma TG & Chol concentrations, up-regulation of FABP mRNA expression induced by HFD
Jongwon et al[32] 2005Rat (obese by HFD)Allium victorialis var. platyphyllum leaves100 mg/kg 2 wk-Considerable reduction of retroperitoneal, epididymal and total abdominal fat pad wt.Sig. decrease in hyperlipidemia and increased lipid content in feces
Kobayashi et al[33] 2001RatEvodiamine an alkaloid of a fruit: Evodia rutaecarpa0/02%, 0/03% of the diet 12 wkC: Control I: ExtractSig. decrease in perirenal fat wt. & decrease of epididymal fat massSig. decrease of lipid in liver & serum FFAs. Sig. increase of lipolytic activity in perirenal fat tissue & specific GDP binding in brown adipose tissue mitochondria as the biological index of heat production
Jin et al[34] 1994RatJiang-zhi jian-fei yao: the refined RhubarbInjected intragastricallyNo sig. increase in body wt. but reduction of food intake. Decreased size of abdominal adipose cellsProlongation of stomach evacuation time and acceleration of intestinal movements
Kim et al[35] 2008RatJuniperus chinensis1% supplement/79 dC: NLD/HFD I: HFD + extractSig. decrease in body wt gain & visceral fat pad wt.Sig. decrease in blood lipid, leptin & insulin levels. Sig. reversal of the down-regulation of genes implicated in adipogenesis & increased gene expressions & phosphorylations related to FABO
Shih et al[36] 2008Mouse (obese by HFD)Momordica charantia (bitter melon)4 wkC: Control I: Rosiglitazone/extractSig. decrease in epididymal white adipose tissue wt. & visceral fat wt.Sig. improvement in blood glucose, leptin, and FFA. Influenced PPARα/PPARγ expression
Pang et al[37] 2008Rat (obese by HFD)Ilex paraguariensisSig. decrease in body wt. of visceral fat-pad wt.Sig. decrease in blood and hepatic lipid, glucose, insulin and leptin levels. Reversed the down-regulation of genes implicated adipogenesis, thermogenesis & enhanced expression of uncoupling proteins in adipose tissue
Bruno et al[38] 2008MouseGreen tea0%, 1%, 2% (wt.:wt.)/6 wkC: Obese/lean I: Same groups + extractSig. decrease in body wt. of both I groupsIn obese I group, sig. decrease in hepatic steatosis was observed dose dependently. Liver enzymes decreased. 30%-41% and 22%-33% lower serum ALT and AST activities were shown, respectively
Lee et al[39] 2008MouseA combination of Morus alba, Melissa officinalis and Artemisia capillaries12 wk-Sig. decrease in body wt. gain & adipose massDecreased serum levels of TG, Chol & inhibited hepatic lipid accumulation, and increased hepatic mRNA levels of enzymes responsible for FABO
Choi et al[40] 2008Mouse (obese by HFD)Cucurbita moschata500 mg/kg 8 wk_Sig. suppression of body wt. & fat storage increase but amount of food intake was not affected
Huang et al 2008[41]RatMomordira charantia L. (Bitter melon)5%C: HFD I1: HFD + plant I2: HFD + thiazolidinedioneSig. decrease in the number of large adipocytes in both I groups. Sig. decrease in adipose tissue mass in I1 group compared to I2 groupSig. decrease in enzymes of adipose tissue implicating reduction of insulin resistance in I group as compared to C group
Lemaure et al[42] 2007Rat (obese)Cyperus rotundus L. tubers45, 220 mg/kg 60 d_Sig. decrease in wt. gain without affecting food consumption
Lei et al[43] 2007MousePomegranate leaf400/800 mg per kilogram 5 wkC: HFD/NLD I: Same groups + extractSig. decrease in body wt. & energy intake and adipose pad wt. percents in I. group. Sig. decrease in appetite of obese mice on NLD was shownSig. decrease in serum TG, Chol, glucose levels & Chol/HDL ratio, inhibition of intestinal fat absorption
Aoki et al[44] 2007Mouse (obese by HFD)Licorice flavonoids oil (LFO)0/5%, 1%, 2% 8 wkC: Placebo I: ExtractSig. decrease of abdominal white adipose tissue & body wt. gain with 1% & 2% LFO groups, decrease of adipocyte sizeImprovement of fatty degeneration of hepatocytes and changes in genes implicating regulation of lipid metabolism with 2% concentration
Oluyemi et al[45] 2007RatGarcinia cambogia seed (bitter cola)200, 400 mg/kg 5 wkC: Placebo I: ExtractSig. decrease in body wt.Sig. decrease in TG pool of adipose tissue & liver but sig. increase of HDL & decreased LDL
Han et al[46] 2006Mouse (obese by HFD)Kochia scoparia1%, 3%/3 d-Prevented the increases in body & parametrial adipose tissue wt.Sig. increase the fecal content & fecal TG levels in day 3
Goyal et al[47] 2006Mouse (obese gold thioglucose)Zingiber officinale250 mg/kg 8 wkC: Placebo I: ExtractSig. decrease in body wt.Sig. decrease in serum Chol, TG, glucose, and insulin
Kishino et al[48] 2006Rat and mouseSalacia reticulata0/5% 8 wk in mice 0/2% 35 d in ratsC: HFD I: HFD + plantSig. decrease in the body wt. and visceral fat mass increaseSig. decrease in plasma TG, 4 h after ingestion; Sig. decrease in energy efficiency, plasma leptin and adiponectine levels
Jayaprakasam et al[49] 2006MouseCornelian cherry (cornus mas) (Purified anthocyanins (A) & ursolic acid (u)1 g/kg (A), 500 mg/kg (u) 8 wkC: HFD I: HFD + A/A + u24% decrease in wt. gain in (A) groupElevated insulin levels; Sig. decrease of liver TG in A + u group
Moreno et al[50] 2006RatArachis hypogaea nutshell1% (wt:wt)/12 wkC: HFD I: HFD + extractSig. decrease in body wt. gain and liver sizeIncreased fecal lipid excretion. Reduced TG content of liver and serum glucose and insulin
Galisteo et al[51] 2005Rat (obese)Plantago Ovata3/5% 25 wkC: STD I: STD + extractSig. decrease in body wt. gainSig. improvement of lipid profile, FFA & insulin & TNF-α & hypoadinectinemia
Zhao et al[52] 2005Mouse (obese by hyperalimentation)Phillyrin (Fructose forsythia)Sig. decrease in wet wt. of fat & fat index & diameter of fat cells & lee indexDecrease in jejunum microvillus area, and serum levels of TG & Chol
Chen et al[53] 2005RatBitter melon (Momordica charantia)0/75% or 7/5 g per kilogram 7 wkC: LFD/HFD I: LFD/HFD + extractLower energy efficiency and visceral fat mass after 4 wk in I groupReduced plasma glucose and hepatic TG but higher serum FFA after 4 wk; Higher plasma catecholamine after 7 wk in I group; Sig. decrease in hepatic TG & steatosis and sig. increase of serum epinephrine & FFA in HFD group of I
Han et al[54] 2005RatColeus forskohlii50 g/kgC: Sham operated/ovariectomized + control diet I: Same groups + extractReduced body wt.& food intake & fat accumulation
Han et al[55] 2005MouseChikusetsu saponins isolated from Panax japonicus rhizomes1%, 3%/9 wkC: HFD I: HFD + extractPrevented body wt. gain & increase of parametrial adipose tissue wt.Sig. increase of the fecal content & TG level in day 3; reduction of plasma TG 2 h after oral lipid intake & inhibition of pancreatic lipase activity
Han et al[56] 2005MouseZingiber officinale Roscoe1%, 3%/8 wkC: HFD I: HFD + plantSig. decrease in body wt. gain at 2-8 wk with 3% & in final parametrial adipose tissue wt. with 1% concentration
Cha et al[57] 2004MouseAcanthopanax senticosus0/5 g per kilogram 12 wkC: NLD/HFD I: NLD/HFD + extractHFD group of I had lower wt. gain but no difference in food consumption was shownIn HFD group of I, lower serum LDL and restoration of liver TG at the same level as fed by LFD was shown; No alteration in carnitine status
Kim et al[58] 2005RatCrude saponin of Korean red ginseng200 mg/kg 3 wk, ipC: NLD/HFD I: NLD/HFD + extractReduced body wt., food intake & fat content in HFD group of I similar to those fed with NLDReduction of hypothalamic NPY expression and serum leptin level in HFD group of I
Yun et al[59] 2004MouseWild Ginseng250, 500 mg/kgC: HFD I: HFD + extractSig. inhibition of body wt. gain dose dependently. Decrease of white & brown adipocytes diametersSig. inhibition of FBG, TG, and FFAs dose-dependently; insulin resistance improved
Junbao et al[60] 2004Rat (obese)Semen cassiae6%-Sig. decrease in body wt. & lee indexReduction of fasting serum TG, insulin & malondialdehyde
Kim et al[61] 2004RatAdlay seed (CoixLachrymajobi var. mayuen)50 mg/100 g of body wt.C1: NLD C2: HFD + saline (sham group) I: HFD + plantSig. decrease in body wt. & food intake & epididymal and peritoneal fat & white adipose tissue size as compared to sham groupIncrease of brown adipocytes as compared to NLD group but not significant
Kwon et al[62] 2003RodentDioscorea nipponica Makino5%/8 wkC: HFD I: HFD + plantSig. decrease in body wt. & adipose gainSuppression of time dependent increase of serum TG level after lipid intake
Lu et al[63] 1999Rat (obese by hyperalimentation)Inspissation tea (Guangdong kudingcha)C: Control I1: Extract I2: FenfluramineStronger modulation on lymphocytes hypertrophy and quantity was shown in I1 groupOnly fenfluramine showed sig. difference in small intestine villus model
Yoshikawa et al[64] 2002Rat (obese)Salacia reticulata125 mg/kg 27 dSuppression of body wt. and periuterine fat storage increase in female rats but no effect on male rats
Xie et al[65] 2002MouseGinseng berry150 mg/kg 12 d, ipC: Diabetic/lean diabetic + placebo I: Same groups + extractSig. decrease in body wt. as compared to day 0 in diabetic group of I. wt. loss in lean mice was shownSig. increase in glucose tolerance in diabetic mice but no sig. decrease of FBG in lean mice.
Yamamoto et al[66] 2000RatCT-II, an extract from Nomame Herba8 wk, 12 wk, 6 moC: Lean/obese + HFD I: Same groups + HFD + plantSig. inhibition of body wt. gain dose dependently without affecting food intake in lean rats after 12 wk. Sig. decrease in body wt. gain in obese mice after 24 wkSig. inhibition of TG elevation
Han et al[67] 1999MouseOolong tea10 wkC: HFD I: HFD + extractNo sig. difference in food intake but prevented obesity & liver induced by a HFDEnhancement of noradrenalin induced lipolysis & inhibition of pancreatic lipase activity
Pusztai et al[68] 1998RatKidney bean (Phaseolus vulgaris)130, 150, 280 g/kg 10-70 dC: Lean/obese + LFD/HFD I: Same groups + extractThe growth was retarded dose-dependently lower body fatSig. decrease of body protein in lean I group. Sig. decrease in plasma insulin levels in obese I group. Sig. pancreatic growth after long term feeding in all I groups
Nagasawa et al[69] 1991Mouse (obese)Tree peony root (Paenia suffruticosa)0/5% 30 wkC: Control I: ExtractSig. decrease in food intake and Lee indexImprovement in glucose tolerance. No sig. difference in serum FFA levels
Wang et al[70] 2008MouseParasitic loranthus from Loranthacea or Viscaceae20 d-Sig. decrease in body wt. & food intakeHigh inhibitory ability on FAS-Loran thacea was nearly 400 fold stronger than that from the viscaceae
Hu et al[71] 2008Mouse (female)Escins extracted from Aesculus turbinata Blume (Hippocastanaceae)2%/11 wkI: HFD C: HFD + extractSuppressed the increase in body & parametrial adipose tissue wt.Suppressed the increase of liver TG content; increased TG in feces after fat ingestion
Ohkoshi et al[72] 2007MouseNelumbo nucifera Gaertn leaves (Nymphaceae)50%C: STD/HFD I: Same groups + extractSig. suppression of body wt. gainExhibition of lipolytic activity especially in visceral adipose tissue; β adrenergic receptor pathway was partly involved
Kang et al[73] 2004RatPM-F2-OB composed of Lycii Fructus, Rehmanniae Radix, Coicis Semen, Carthami Flos, Hoelen, Angelicae Radix, Nelumbinis Semen, Radix Dioscorea and Aurantii Fructus6 wkC: STD/HFD I: Same groups + plantNo sig. difference in wt. change if STD was used but in HFD group of I resulted in sig. decrease in body wt. gain but showed no sig. difference in amount of food intakeSig. decrease in serum Chol/LDL and total lipids; reduction of kidney fat wt./FFA/PL & TG to levels equal or below the normal diet
Mary et al[74] 2003RabbitCaps HT2 A herbal formulation5 mg/kg (iv) 30 d 100/200/300/400/mg per kilogram orally-Sig. decrease in body wt.Sig. increase in HDL after oral administration and decrease in atherogenic index in oral administration; Sig. increase of the release of LPL enzyme and sig. hypolipidemic effect in IV groups
Wu et al[75] 2005Rat (diabetic by STZ )Astragalus polysaccharide (APS) a component of Astragalus membranaceus roots400 mg/kg (APS) 5 wk-Sig. decrease in body wt.Sig. decrease in plasma glucose; improved insulin sensitivity
Xie et al[76] 2005Mouse (Genetically obese)Total, Ginsenosides in Chinese ginseng (TG CG), from leaves and the stem of Panax ginseng100, 200 mg/kg (ip) 12 wk & 150, 300 mg/kg (oral)/12 wkC: Placebo I: ExtractSig. decrease in body wt.Sig. decrease in FBG in 200 mg/kg dose after injection Sig. decrease in FBG in 300 mg/kg dose
Palit et al[77] 1999MouseGalega officinalis10% (w/w) of the diet 28 dC: Diabetic/NL I: Same groups + plantSig. decrease in body wt. in both I groups, sig. wt. loss in normal mice independent of a reduction in food intake but in diabetic mice wt. loss was with reduced food intakeStriking loss of body fat in both groups; Sig. decrease in serum glucose in both groups but Sig. decrease in serum insulin in diabetic mice
Oi et al[78] 1999RatGarlic8 g/kg of diet 28 dC: HFD I: HFD + extractSig. decrease in body wt. & perirenal adipose tissue wt. & epididymal fat padSig. decrease in plasma TG levels; sig. decrease in mitochondrial protein and (UCP) in brown adipose tissue, and in urinary noradrenaline and adrenaline excretion
Yoshida et al[79] 1995Mouse (obese and lean)Bofu-tsusho-san1/4%, 4/7% of wt. of food 8 wk-Sig. decrease in body wt. & retroperitoneal white adipose tissue wt. and no change in food intakeSig. increase in GDP binding dose dependently
He et al[80] 2008Rat (obese by STZ & HFDYi-Qi-Yang-Yin-Ye2, 4, 8 g/kg 4 wk-Body wt. decreasedDecrease in TG/Chol/LDL/FFA/FBG/insulin; improvement of glucose tolerance
Jeong et al[81] 2008Rat (fatty)Gyeongshang angjeehwan: Liriope platyphylla F.T./Wang & T. Tang (Liliaceae), Platycodongrandiflorum A. DC. (Campanulaceae). Schisandrachinensis K. Koch (Magnoliaceae). Ephedra sinica Stapf (Ephedraceae)8 wkC: Placebo I: CompoundSig. decrease in food intake & body wt. gain & abdominal fatSig. decrease in plasma leptin levels; decrease in circulating TG and inhibition of lipid accumulation in liver; increase of mRNA of genes responsible for FABO
Park et al[82] 2005Rat (obese by diet)Platycodon grandiflorum150 mg/kg 7 wkC: Convert to NLD/HFD I: Same groups + extractSig. decrease in wt. of body & adipose tissues in rats converted to NLD as compared to those remained on HFDSig. decrease in fat cell number & size in both I groups as compared to their state before intervention; decrease of FABP expression in HFD group of I
Akagiri et al[83] 2008Mouse (obese by HFD)Bofutsushosan (BOF)1%/4 wkC: Placebo I: CompoundThe wt. of WAT and increase in size of adipocytes inhibitedExpression of UCP1 mRNA in WAT was found but not sig.
Kim et al[84] 2005Mouse (diabetic)Pine extract (bark and needle)21 dC: Control I: ExtractSig. decrease in body wt.Effectively suppressed the increase of postprandial blood glucose level by delaying absorption of diet
Attele et al[85] 2002Mouse (obese diabetic)Panax ginseng berry150 mg/kg (ip) 12 dC: Control I: ExtractSig. loss of wt. with a sig. reduction in food intake & a very sig. increase in energy expenditure & body temperatureSig. improvement in glucose tolerance & sig. reduction in serum insulin levels & plasma chol levels